Graft versus leukemia effect against juvenile myelomonocytic leukemia after unrelated cord blood transplantation

被引:13
作者
Tanoshima, Reo [1 ]
Goto, Hiroaki [1 ]
Yanagimachi, Masakatsu [1 ]
Kajiwara, Ryosuke [1 ]
Kuroki, Fumiko [1 ]
Yokota, Shumpei [1 ]
机构
[1] Yokohama City Univ, Dept Pediat, Kanagawa 23650004, Japan
关键词
cord blood transplantation; graft versus leukemia effect; JMML;
D O I
10.1002/pbc.21200
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A 13-month-old female underwent unrelated cord blood transplantation (CBT) for juvenile myelomonocytic leukemia (JMML). In spite of progression of the disease after a conditioning regimen with high-dose chemotherapy, a complete remission was induced in concordance with development of acute GVHD after reduction of the immunosupressant. She has been in complete remission for 1 year after transplantation. This case illustrates that CBT can provide a potent graft versus leukemia (GVL) effect against JMML.
引用
收藏
页码:665 / 667
页数:3
相关论文
共 9 条
[1]   Juvenile myelomonocytic leukemia [J].
Arico, M ;
Biondi, A ;
Pui, CH .
BLOOD, 1997, 90 (02) :479-488
[2]  
CASTROMALASPINA H, 1984, CANCER, V54, P675, DOI 10.1002/1097-0142(1984)54:4<675::AID-CNCR2820540415>3.0.CO
[3]  
2-Q
[4]   Umbilical cord blood transplantation - how, when and for whom? [J].
Cohen, Y ;
Nagler, A .
BLOOD REVIEWS, 2004, 18 (03) :167-179
[5]  
HOUGH RH, 2002, BLOOD, V100
[6]   Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML):: results of the EWOG-MDS/EBMT trial [J].
Locatelli, F ;
Nöllke, P ;
Zecca, M ;
Korthof, E ;
Lanino, E ;
Peters, C ;
Pession, A ;
Kabisch, H ;
Uderzo, C ;
Bonfim, CS ;
Bader, P ;
Dilloo, D ;
Stary, J ;
Fischer, A ;
Révész, T ;
Führer, M ;
Hasle, H ;
Trebo, M ;
van den Heuvel-Eibrink, MM ;
Fenu, S ;
Strahm, B ;
Giorgiani, G ;
Bonora, MR ;
Duffner, U ;
Niemeyer, CM .
BLOOD, 2005, 105 (01) :410-419
[7]  
Niemeyer CM, 1998, BLOOD, V91, P365
[8]  
NIEMEYER CM, 1997, BLOOD, V89, P479
[9]   Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia [J].
Yoshimi, A ;
Bader, P ;
Matthes-Martin, S ;
Stary, J ;
Sedlacek, P ;
Duffner, U ;
Klingebiel, T ;
Dilloo, D ;
Holter, W ;
Zintl, F ;
Kremens, B ;
Sykora, KW ;
Urban, C ;
Hasle, H ;
Korthof, E ;
Révész, T ;
Fischer, A ;
Nöllke, P ;
Locatelli, F ;
Niemeyer, CM .
LEUKEMIA, 2005, 19 (06) :971-977